Stock NXTCL NEXTCELL PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Other languages NextCell Pharma AB

Equities

NXTCL

SE0009723125

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:59 29/05/2024 BST 		5-day change 1st Jan Change
2.38 SEK -37.37% Intraday chart for NextCell Pharma AB +65.85% -9.51%
05-27 Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board CI
04-25 NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024
NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue
Anders Essen-Möller Resigns as Chairman of NextCell Pharma AB
The Swedish Medical Products Agency Approves Subgroup Analysis in NextCell Pharma AB's ProTrans-Young study
NextCell Pharma AB Establishes QVance to Meet the Nordic's Need for Quality Analytics
NextCell Pharma AB Reports Earnings Results for the First Quarter Ended November 30, 2023
Nextcell Pharma Announces Updates Regarding Nextcell's Clinical Trials with Protrans
NextCell Pharma AB Announces Repeated Treatment with ProTrans Is Immunologically Safe
NextCell Pharma AB Reports Earnings Results for the Full Year Ended August 31, 2023
NextCell Pharma AB Reports Earnings Results for the Fourth Quarter Ended August 31, 2023
Nextcell Pharma, Lino Signs Distribution Deal in Sweden
Nextcell Pharma AB Signs an Agreement for A New Tissue Product with Linio
NextCell Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023
NextCell Pharma Moves to Last Stage of Pneumonia Therapy Study
NextCell Pharma AB Announces Treatment Start of Severe Pneumonia with High Dose of ProTrans
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023
FDA Approves a Product of Multiplied Stem Cells from Umbilical Cord Blood of NextCell Pharma AB
Nextcell Pharma AB Publishes the Phase I/II Clinical Trial in Type I Diabetes Accepted
NextCell Pharma AB Reports Earnings Results for the First Quarter Ended November 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NXTCL Stock
  4. News NextCell Pharma AB
  5. Other languages